Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells

Molecular and Cellular Endocrinology

Volumn 355, Issue 1, 2012, Pages 60-70

  Evans, Jodi F ^a,b   Fernando, Anne ^a   Ragolia, Louis ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

ACTH; Macrophage; Mesenchymal; Paracrine; Proopiomelanocortin

Indexed keywords

CALCIUM ION; COLLAGEN; CORTICOTROPIN; FURA 2; LIPID; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; PROLINE; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; TRITIUM;

ANIMAL CELL; AORTA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CLONE; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOBLOTTING; INTRACELLULAR TRANSPORT; LIPID STORAGE; MACROPHAGE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; AORTA; AZO COMPOUNDS; CALCIUM; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX; FURA-2; GENE EXPRESSION; MACROPHAGES; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; PRO-OPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; RATS; RATS, INBRED WKY; RECEPTOR, MELANOCORTIN, TYPE 2; RECEPTOR, MELANOCORTIN, TYPE 3; SIGNAL TRANSDUCTION;

EID: 84858751036     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.01.019     Document Type: Article

References (49)

1. Adiguzel E., Ahmad P.J., Franco C., Bendeck M.P. Collagens in the progression and complications of atherosclerosis. Vasc. Med. 2009, 14:73-89.
2. Adiguzel E., Hou G., Mulholland D., Hopfer U., Fukai N., Olsen B., Bendeck M. Migration and growth are attenuated in vascular smooth muscle cells with type VIII collagen-null alleles. Arterioscler. Thromb. Vasc. Biol. 2006, 26:56-61.
3. Bicknell A.B. The tissue-specific processing of pro-opiomelanocortin. J. Neuroendocrinol. 2008, 20:692-699.
4. Boston B.A. The role of melanocortins in adipocyte function. Ann. NY Acad. Sci. 1999, 885:75-84.
5. Butler A.A. The melanocortin system and energy balance. Peptides 2006, 27:281-290.
6. Catania A. The melanocortin system in leukocyte biology. J. Leukoc. Biol. 2007, 81:383-392.
7. Catania A., Lonati C., Sordi A., Carlin A., Leonardi P., Gatti S. The melanocortin system in control of inflammation. ScientificWorldJournal 2010, 10:1840-1853.
8. Cone R.D. Studies on the physiological functions of the melanocortin system. Endocr. Rev. 2006, 27:736-749.
9. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006, 119:2204-2213.
10. Evans J.F., Niu Q.T., Canas J.A., Shen C.L., Aloia J.F., Yeh J.K. ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes. Bone 2004, 35:96-107.
11. Evans J.F., Shen C.L., Pollack S., Aloia J.F., Yeh J.K. Adrenocorticotropin evokes transient elevations in intracellular free calcium ([Ca2+]i) and increases basal [Ca2+]i in resting chondrocytes through a phospholipase C-dependent mechanism. Endocrinology 2005, 146:3123-3132.
12. Gallo-Payet N., Payet M.D. Mechanism of action of ACTH: beyond cAMP. Microsc. Res. Tech. 2003, 61:275-287.
13. Gatti S., Lonati C., Sordi A., Catania A. Protective effects of melanocortins in systemic host reactions. Adv. Exp. Med. Biol. 2010, 681:117-125.
14. Getting S.J., Allcock G.H., Flower R., Perretti M. Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol. 2001, 69:98-104.
15. Gil-Lozano M., Perez-Tilve D., Alvarez-Crespo M., Martis A., Fernandez A.M., Catalina P.A., Gonzalez-Matias L.C., Mallo F. GLP-1(7-36)-amide and Exendin-4 stimulate the HPA axis in rodents and humans. Endocrinology 2010, 151:2629-2640.
16. Harbour D.V., Smith E.M., Blalock J.E. Novel processing pathway for proopiomelanocortin in lymphocytes: endotoxin induction of a new prohormone-cleaving enzyme. J. Neurosci. Res. 1987, 18:95-101.
17. Holloway P.M., Smith H.K., Renshaw D., Flower R.J., Getting S.J., Gavins F.N. Targeting the melanocortin receptor system for anti-stroke therapy. Trends Pharmacol. Sci. 2011, 32:90-98.
18. Hoogduijn M.J., McGurk S., Smit N.P., Nibbering P.H., Ancans J., van der Laarse A., Thody A.J. Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca(2+)](I). Biochem. Biophys. Res. Commun. 2002, 290:844-850.
19. Horrocks P.M., Jones A.F., Ratcliffe W.A., Holder G., White A., Holder R., Ratcliffe J.G., London D.R. Patterns of ACTH and cortisol pulsatility over twenty-four hours in normal males and females. Clin. Endocrinol. (Oxf) 1990, 32:127-134.
20. Isales C.M., Zaidi M., Blair H.C. ACTH is a novel regulator of bone mass. Ann. NY Acad. Sci. 2010, 1192:110-116.
21. Jun D.J., Na K.Y., Kim W., Kwak D., Kwon E.J., Yoon J.H., Yea K., Lee H., Kim J., Suh P.G., et al. Melanocortins induce interleukin 6 gene expression and secretion through melanocortin receptors 2 and 5 in 3T3-L1 adipocytes. J. Mol. Endocrinol. 2010, 44:225-236.
22. Le Pape E., Wakamatsu K., Ito S., Wolber R., Hearing V.J. Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor. Pigment Cell Melanoma Res 2008, 21:477-486.
23. Lee S.N., Prodhomme E., Lindberg I. Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS. J. Endocrinol. 2004, 182:353-364.
24. Leoni G., Voisin M.B., Carlson K., Getting S., Nourshargh S., Perretti M. The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. Br. J. Pharmacol. 2010, 160:171-180.
25. Martinet W., De Meyer G.R. Selective depletion of macrophages in atherosclerotic plaques: myth, hype, or reality?. Circ. Res. 2007, 100:751-753.
26. Montero-Melendez T., Patel H.B., Perretti M. Role of melanocortin receptors in the regulation of gouty inflammation. Curr. Rheumatol. Rep. 2011, 13:138-145.
27. Muceniece R., Dambrova M. Melanocortins in brain inflammation: the role of melanocortin receptor subtypes. Adv. Exp. Med. Biol. 2010, 681:61-70.
28. Murakami H., Nigawara T., Sakihara S., Kageyama K., Yamashita M., Matsuki K., Tanabe J., Matsui J., Tamasawa N., Suda T. The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical Cushing's disease. Endocr. J. 2010, 57:267-272.
29. Neves S.R., Ram P.T., Iyengar R. G protein pathways. Science 2002, 296:1636-1639.
30. Noon L.A., Clark A.J., King P.J. A peroxisome proliferator-response element in the murine mc2-r promoter regulates its transcriptional activation during differentiation of 3T3-L1 adipocytes. J. Biol. Chem. 2004, 279:22803-22808.
31. Patel H.B., Leoni G., Melendez T.M., Sampaio A.L., Perretti M. Melanocortin control of cell trafficking in vascular inflammation. Adv. Exp. Med. Biol. 2010, 681:88-106.
32. Rajora N., Ceriani G., Catania A., Star R.A., Murphy M.T., Lipton J.M. Alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J. Leukoc. Biol. 1996, 59:248-253.
33. Sebag J.A., Hinkle P.M. Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers. Proc. Natl. Acad. Sci. USA 2007, 104:20244-20249.
34. Shin M.K., Kim M.K., Bae Y.S., Jo I., Lee S.J., Chung C.P., Park Y.J., Min do S. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells. Cell. Signal. 2008, 20:613-624.
35. Smith S.R., Gawronska-Kozak B., Janderova L., Nguyen T., Murrell A., Stephens J.M., Mynatt R.L. Agouti expression in human adipose tissue: functional consequences and increased expression in type 2 diabetes. Diabetes 2003, 52:2914-2922.
36. Star R.A., Rajora N., Huang J., Stock R.C., Catania A., Lipton J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA 1995, 92:8016-8020.
37. Stary H.C., Chandler A.B., Glagov S., Guyton J.R., Insull W., Rosenfeld M.E., Schaffer S.A., Schwartz C.J., Wagner W.D., Wissler R.W. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. 1994, 14:840-856.
38. Stewart P.M., Gibson S., Crosby S.R., Penn R., Holder R., Ferry D., Thatcher N., Phillips P., London D.R., White A. ACTH precursors characterize the ectopic ACTH syndrome. Clin. Endocrinol. (Oxf) 1994, 40:199-204.
39. Stoneman V., Braganza D., Figg N., Mercer J., Lang R., Goddard M., Bennett M. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 2007, 100:884-893.
40. Sutton G.M., Trevaskis J.L., Hulver M.W., McMillan R.P., Markward N.J., Babin M.J., Meyer E.A., Butler A.A. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 2006, 147:2183-2196.
41. Talbot J.A., Kane J.W., White A. Analytical and clinical aspects of adrenocorticotrophin determination. Ann. Clin. Biochem. 2003, 40:453-471.
42. van der Kraan M., Adan R.A., Entwistle M.L., Gispen W.H., Burbach J.P., Tatro J.B. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 1998, 139:2348-2355.
43. Veo K., Reinick C., Liang L., Moser E., Angleson J.K., Dores R.M. Observations on the ligand selectivity of the melanocortin 2 receptor. Gen. Comp. Endocrinol. 2011, 172:3-9.
44. Wang Q., Zhong S., Ouyang J., Jiang L., Zhang Z., Xie Y., Luo S. Osteogenesis of electrically stimulated bone cells mediated in part by calcium ions. Clin. Orthop. Relat. Res. 1998, 259-268.
45. Yang Y. Structure, function and regulation of the melanocortin receptors. Eur. J. Pharmacol. 2011, 660:125-130.
46. Yeh J.K., Evans J.F., Chen M.M., Aloia J.F. Effect of hypophysectomy on the proliferation and differentiation of rat bone marrow stromal cells. Am. J. Physiol. 1999, 276:E34-42.
47. Zaidi M., Sun L., Robinson L.J., Tourkova I.L., Liu L., Wang Y., Zhu L.L., Liu X., Li J., Peng Y., et al. ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc. Natl. Acad. Sci. USA 2010, 107:8782-8787.
48. Zhang, W., Chen, D.Q., Qi, F., Wang, J., Xiao, W.Y., Zhu, W.Z., 2010. Inhibition of calcium-calmodulin-dependent kinase II suppresses cardiac fibroblast proliferation and extracellular matrix secretion. J. Cardiovasc. Pharmacol. 55, 96-105.
49. Zhong Q., Sridhar S., Ruan L., Ding K.H., Xie D., Insogna K., Kang B., Xu J., Bollag R.J., Isales C.M. Multiple melanocortin receptors are expressed in bone cells. Bone 2005, 36:820-831.